By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – NanoString Technologies said late on Monday it has licensed worldwide rights to Bioclassifier technology to develop in vitro diagnostic and research products for breast cancer intrinsic subtyping.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
A genome-wide association study highlights a potential role for hair follicles in acne risk, according to New Scientist.
Newsday reports that breast cancer genetic testing guidelines for are out of date and may miss individuals.
In Cell this week: gene editing-based strategy to screen for immune system regulators, ancient plague patterns, and more.
Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.